Characteristics of activation of monocyte-derived macrophages versus microglia after mouse experimental intracerebral

Fenghui Ye1, Jinting Yang1, Katherine G Holste1

  • 1Department of Neurosurgery, University of Michigan, Ann Arbor, MI, USA.

Insights

Monocyte-derived macrophages (MDMs) are crucial for clearing blood clots after intracerebral hemorrhage (ICH). Enhancing MDM phagocytosis with CD47 blocking antibodies shows therapeutic potential for ICH recovery.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Intracerebral hemorrhage (ICH) triggers inflammatory responses involving microglia and monocyte-derived macrophages (MDMs).
  • Understanding the roles of these immune cells is key to developing effective treatments for ICH.

Purpose of the Study:

  • To investigate the dynamic roles of MDMs and microglia in hematoma resolution post-ICH.
  • To evaluate the impact of CD47 blockade and phagocyte depletion on immune cell infiltration and activity.

Main Methods:

  • Utilized Tmem119-EGFP transgenic mice and F4/80 immunohistochemistry to track microglia and MDMs.
  • Established a murine ICH model with autologous blood injection, co-administered with CD47 blocking antibodies or clodronate liposomes.
  • Administered blood components (Prx2, thrombin) to assess their chemoattractant properties for MDMs.

Main Results:

  • MDMs formed a peri-hematoma layer by day 3 post-ICH, with giant phagocytes observed.
  • CD47 blockade increased MDM presence and phagocytic activity up to day 7.
  • Clodronate liposomes reduced both MDMs and microglia.
  • Peroxiredoxin 2 (Prx2) attracted MDMs into the brain parenchyma.

Conclusions:

  • MDMs play a significant role in phagocytosis during ICH hematoma resolution.
  • CD47 blockade enhances MDM phagocytic capacity, presenting a potential therapeutic strategy.
  • Targeting MDM function offers a promising avenue for future ICH treatments.

Related Concept Videos